Endomag operates as a medical device company designed to detect breast cancer. The Company offers: Sentimag, an instrument for ultrasensitive detection in pre-and post-incision use for a range of hospitals and clinics; Sienna, a tracer that produces a transient magnetic response; Magseed to guide surgeons using Sentimag during a breast lumpectomy; Magtrace, a non-radioactive dual-tracer for lymphatic mapping in patients with breast cancer undergoing a mastectomy; and Siennova, a therapeutic hyperthermia system used as an adjuvant to chemo- and radiotherapy.
|Employees (est.) (Nov 2020)||44||(+13%)|
Endomag total Funding
Endomag latest funding size
Time since last funding
|2 years ago|
|Draper Esprit, Sussex Place Ventures, New Wave Ventures, UCLB, Bloomsbury Bioseed Fund, Sarum Partners|
|GBP||FY, 2013||FY, 2014||FY, 2015||FY, 2016||FY, 2017||FY, 2018|
Endomag has 2.19k Twitter Followers. The number of followers has increased 3.2% month over month and increased 3.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Endomag founded?
Endomag was founded in 2007.
Who are Endomag key executives?
Endomag's key executives are John Gonzalez, Andrew Shawcross and Eric Mayes.
How many employees does Endomag have?
Endomag has 44 employees.
Who are Endomag competitors?
Competitors of Endomag include Nu-Med Plus, NeoChord and Inspire Medical Systems.
Where is Endomag headquarters?
Endomag headquarters is located at tower 42, 33rd floor, 25 Old Broad St, Cornhill, London.
Where are Endomag offices?
Endomag has offices in London, Milton, Austin and Wilmington.
How many offices does Endomag have?
Endomag has 4 offices.
Receive alerts for 300+ data fields across thousands of companies